athenahealth, Inc. (ATHN) Misses Q1 EPS by 5c
Get Alerts ATHN Hot Sheet
Price: $9.59 --0%
Financial Fact:
Research and development: 24.86M
Today's EPS Names:
EGRX, MOVE, MDRX, More
Financial Fact:
Research and development: 24.86M
Today's EPS Names:
EGRX, MOVE, MDRX, More
Join SI Premium – FREE
athenahealth, Inc. (NASDAQ: ATHN) reported Q1 EPS of $0.12, $0.05 worse than the analyst estimate of $0.17. Revenue for the quarter came in at $163 million versus the consensus estimate of $170.03 million.
- For the three months ended March 31, 2014, Non-GAAP Adjusted Gross Margin was 59.8%, down slightly from 60.4% in the same period last year.
- For the three months ended March 31, 2014, Non-GAAP Adjusted Operating Income was $8.7 million, or 5.4% of total revenue, compared to Non-GAAP Adjusted Operating Income of $9.4 million, or 7.5% of total revenue, in the same period last year.
- For the three months ended March 31, 2014, GAAP Net Loss was $8.1 million, or $0.21 per diluted share, compared to GAAP Net Income of $0.7 million, or $0.02 per diluted share, in the same period last year.
For earnings history and earnings-related data on athenahealth, Inc. (ATHN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nomura/Instinet Upgrades Genting Singapore (GENS:SP) (GIGNY) to Neutral
- Instil Bio Inc. (TIL) Misses Q2 EPS by 21c
- Calidi Biotherapeutics (CLDI) Reports Q2 Loss of $2.94
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share